{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T23:36:19Z","timestamp":1762731379918,"version":"build-2065373602"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,9]]},"DOI":"10.7759\/cureus.96441","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T23:32:57Z","timestamp":1762731177000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcome and Prognostication of Patients With Inflammatory and Immune Myopathies With and Without Chemotherapy in the United States"],"prefix":"10.7759","author":[{"given":"Baljinder","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simrandeep K","family":"Brar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elina","family":"Zakin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg IE","year":"2021","unstructured":"Lundberg IE, Fujimoto M, Vencovsky J, et al.. Idiopathic inflammatory myopathies. Nat Rev Dis Primers. 2021, 7:86. 10.1038\/s41572-021-00321-x","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.17-4-322","article-title":"Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment","volume":"17","author":"Oldroyd A","year":"2017","unstructured":"Oldroyd A, Lilleker J, Chinoy H. Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment. Clin Med (Lond). 2017, 17:322-8. 10.7861\/clinmedicine.17-4-322","journal-title":"Clin Med (Lond)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.06.005","article-title":"Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort","volume":"45","author":"Dobloug GC","year":"2015","unstructured":"Dobloug GC, Garen T, Brunborg C, Gran JT, Molberg \u00d8. Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort. Semin Arthritis Rheum. 2015, 45:301-8. 10.1016\/j.semarthrit.2015.06.005","journal-title":"Semin Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/08916930600622645","article-title":"Clinical implications of autoantibody screening in patients with autoimmune myositis","volume":"39","author":"Ghirardello A","year":"2006","unstructured":"Ghirardello A, Zampieri S, Tarricone E, et al.. Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity. 2006, 39:217-21. 10.1080\/08916930600622645","journal-title":"Autoimmunity"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/ar1862","article-title":"In adult onset myositis, the presence of interstitial lung disease and myositis specific\/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype","volume":"8","author":"Chinoy H","year":"2006","unstructured":"Chinoy H, Salway F, Fertig N, et al.. In adult onset myositis, the presence of interstitial lung disease and myositis specific\/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype. Arthritis Res Ther. 2006, 8:R13. 10.1186\/ar1862","journal-title":"Arthritis Res Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep248","article-title":"HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy","author":"Chinoy H","year":"2009","unstructured":"Chinoy H, Payne D, Poulton KV, et al.. HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy. 2009. 10.1093\/rheumatology\/kep248"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2010.04.004","article-title":"Idiopathic inflammatory myopathies with anti-PM-Scl antibodies: case series and literature review (Article in French)","volume":"31","author":"Marie I","year":"2010","unstructured":"Marie I, Lahaxe L, Tiev K, Duval-Modeste AB, Vittecoq O, Levesque H, Jouen F. Idiopathic inflammatory myopathies with anti-PM-Scl antibodies: case series and literature review (Article in French). Rev Med Interne. 2010, 31:540-4. 10.1016\/j.revmed.2010.04.004","journal-title":"Rev Med Interne"},{"key":"ref8","unstructured":"HCUP Databases. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality. NIS Overview. . Accessed.  September 28, 2025: https:\/\/hcup-us.ahrq.gov\/nisoverview.jsp."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyz359","article-title":"Mechanical thrombectomy in acute ischemic stroke patients performed within and outside clinical trials in the United States","volume":"86","author":"Qureshi AI","year":"2020","unstructured":"Qureshi AI, Singh B, Huang W, Du Z, Lobanova I, Liaqat J, Siddiq F. Mechanical thrombectomy in acute ischemic stroke patients performed within and outside clinical trials in the United States. Neurosurgery. 2020, 86:E2-8. 10.1093\/neuros\/nyz359","journal-title":"Neurosurgery"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-019-1107-y","article-title":"Epidemiology of diabetes mellitus and cardiovascular disease","volume":"21","author":"Glovaci D","year":"2019","unstructured":"Glovaci D, Fan W, Wong ND. Epidemiology of diabetes mellitus and cardiovascular disease. Curr Cardiol Rep. 2019, 21:21. 10.1007\/s11886-019-1107-y","journal-title":"Curr Cardiol Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000000778","article-title":"Diabetes mellitus and sepsis: a challenging association","volume":"47","author":"Trevelin SC","year":"2017","unstructured":"Trevelin SC, Carlos D, Beretta M, da Silva JS, Cunha FQ. Diabetes mellitus and sepsis: a challenging association. Shock. 2017, 47:276-87. 10.1097\/SHK.0000000000000778","journal-title":"Shock"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2015-011674","article-title":"Trends in mortality following mechanical thrombectomy for the treatment of acute ischemic stroke in the USA","volume":"8","author":"Villwock MR","year":"2016","unstructured":"Villwock MR, Padalino DJ, Deshaies EM. Trends in mortality following mechanical thrombectomy for the treatment of acute ischemic stroke in the USA. J Neurointerv Surg. 2016, 8:457-60. 10.1136\/neurintsurg-2015-011674","journal-title":"J Neurointerv Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3233\/JND-180308","article-title":"Current classification and management of inflammatory myopathies","volume":"5","author":"Schmidt J","year":"2018","unstructured":"Schmidt J. Current classification and management of inflammatory myopathies. J Neuromuscul Dis. 2018, 5:109-29. 10.3233\/JND-180308","journal-title":"J Neuromuscul Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.08.060","article-title":"Inflammatory myopathies and lymphoma","volume":"369","author":"St\u00fcbgen JP","year":"2016","unstructured":"St\u00fcbgen JP. Inflammatory myopathies and lymphoma. J Neurol Sci. 2016, 369:377-89. 10.1016\/j.jns.2016.08.060","journal-title":"J Neurol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2012.04.014","article-title":"Cardiotoxicity of chemotherapies (Article in French)","volume":"42","author":"Castel M","year":"2013","unstructured":"Castel M, Despas F, Modesto A, et al.. Cardiotoxicity of chemotherapies (Article in French). Presse Med. 2013, 42:26-39. 10.1016\/j.lpm.2012.04.014","journal-title":"Presse Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-022-00990-1","article-title":"Tumor lysis syndrome, acute kidney injury and disease-free survival in critically ill patients requiring urgent chemotherapy","volume":"12","author":"Abdel-Nabey M","year":"2022","unstructured":"Abdel-Nabey M, Chaba A, Serre J, Lenglin\u00e9 E, Azoulay E, Darmon M, Zafrani L. Tumor lysis syndrome, acute kidney injury and disease-free survival in critically ill patients requiring urgent chemotherapy. Ann Intensive Care. 2022, 12:15. 10.1186\/s13613-022-00990-1","journal-title":"Ann Intensive Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/422547-clinical-outcome-and-prognostication-of-patients-with-inflammatory-and-immune-myopathies-with-and-without-chemotherapy-in-the-united-states","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T23:33:06Z","timestamp":1762731186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/422547-clinical-outcome-and-prognostication-of-patients-with-inflammatory-and-immune-myopathies-with-and-without-chemotherapy-in-the-united-states"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,9]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.96441","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,9]]}}}